Taken from Commsec Business Summary Tissue Therapies Limited...

Taken from Commsec
Business Summary

Tissue Therapies Limited (TIS) is an Australian biomedical technology company which develops treatments for acute and chronic wound healing applications, including chronic skin ulcers and burns. TIS is commercialising VitroGro ECM, a technology for cell based therapies. TIS is also developing treatments for psoriasis, scar prevention and various cancers including those of the breast, colon and prostate.